136 related articles for article (PubMed ID: 34397030)
1. The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients.
Baysal M; Bas V; Demirci U; Gulsaran SK; Umit E; Kirkizlar HO; Demir AM
Niger J Clin Pract; 2021 Aug; 24(8):1194-1199. PubMed ID: 34397030
[TBL] [Abstract][Full Text] [Related]
2. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
[TBL] [Abstract][Full Text] [Related]
3. The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Kaneda Y; Kanemura N; Nakamura N; Ikoma Y; Yamaguchi K; Takada E; Shibata Y; Lee S; Fujita K; Morishita T; Matsumoto T; Nakamura H; Kitagawa J; Kasahara S; Hara T; Tsurumi H; Shimizu M
Leuk Lymphoma; 2024 Mar; 65(3):339-345. PubMed ID: 38124378
[TBL] [Abstract][Full Text] [Related]
4. Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?
Akgün Çağlıyan G; Hacıoğlu S; Ünver Koluman B; İlkkılıç K; Nar R; Başer MN; Bozdemir A; Şenol H; Şen Türk N; Erol V; Yılıdırım O; Çağlıyan Ö; Güler N
Turk J Med Sci; 2021 Aug; 51(4):2112-2119. PubMed ID: 33957727
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma.
Nagata A; Kanemasa Y; Sasaki Y; Nakamura S; Okuya T; Funasaka C; Kageyama A; Shimoyama T; Omuro Y
Hematol Oncol; 2020 Aug; 38(3):309-317. PubMed ID: 32223021
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma.
Go SI; Choi BH; Park MJ; Park S; Kang MH; Kim HG; Kang JH; Jeong EJ; Lee GW
BMC Cancer; 2023 Nov; 23(1):1071. PubMed ID: 37932700
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.
Zhang S; Sun C; Chen X; Li D; Hu L; Zhang M; Zhang X; Zhang H; Ye J; Wang L; Jia T; Zhu T; Miao Y; Wang C; Wang L; Yan D; Shen Z; Sang W
Ann Hematol; 2023 Jun; 102(6):1433-1442. PubMed ID: 37074377
[TBL] [Abstract][Full Text] [Related]
8. The clinical impacts of the controlling nutritional status score on patients with Hodgkin lymphoma.
Gürsoy V; Hunutlu FÇ; Pinar IE; Göktuğ MR; Ali R; Özkocaman V; Özkalemkaş F
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9916-9927. PubMed ID: 37916361
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of controlling nutritional status score in hematological malignancies.
Zhang Y; Chen Q; Lu C; Yu L
Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma.
Liu T; Hu R; Lv J; Luo Q; Xu L; Wang C; Liu J; Yang Z; Xu L; Liu Y
Front Nutr; 2022; 9():1050139. PubMed ID: 36438738
[TBL] [Abstract][Full Text] [Related]
11. A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.
Wu W; Ren K; Chen X; Li N; Zhou H; Jiang M; Yu Y; Zou L
Cancer Med; 2023 Apr; 12(8):9439-9448. PubMed ID: 36866811
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of the Controlling Nutritional Status (CONUT) score in patients with lymphoma: a meta-analysis.
Li L; Shou L
BMJ Open; 2024 Mar; 14(3):e078320. PubMed ID: 38453197
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
Xue W; Zhang Y; Wang H; Zhang Y; Hu X
Front Immunol; 2021; 12():778746. PubMed ID: 34917092
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer.
Li Y; Zhang C; Ji R; Lu H; Zhang W; Li LL; Liu R; Qian H; He A
Int J Gynecol Cancer; 2020 Jan; 30(1):74-82. PubMed ID: 31822507
[TBL] [Abstract][Full Text] [Related]
15. Combined Features Based on Preoperative Controlling Nutritional Status Score and Circulating Tumour Cell Status Predict Prognosis for Colorectal Cancer Patients Treated with Curative Resection.
Yang C; Wei C; Wang S; Han S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(6):1325-1335. PubMed ID: 31223290
[No Abstract] [Full Text] [Related]
16. Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
Liu X; Zhang D; Lin E; Chen Y; Li W; Chen Y; Sun X; Zhou Z
BMC Cancer; 2018 Jun; 18(1):699. PubMed ID: 29954375
[TBL] [Abstract][Full Text] [Related]
17. Controlling Nutritional Status (CONUT) score as immune-nutritional predictor of outcomes in patients undergoing peritoneal dialysis.
Zhou H; Chao W; Cui L; Li M; Zou Y; Yang M
Clin Nutr; 2020 Aug; 39(8):2564-2570. PubMed ID: 31787366
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
19. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
20. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
